INNOVADERM CRO IS NOW INDERO.

Your Aesthetics CRO

Specialized, hands-on support for your aesthetics and cosmetics studies. We’re all in.

Is Now

For over two decades, Innovaderm has been the leading dermatology CRO and one of the largest dermatology Clinical Research Units (CRU) in North America. As we continue to grow and support immune-mediated diseases—including those in rheumatology, a therapeutic area inextricably linked to dermatology—we have rebranded the CRO side of our business to InderoOur CRU will retain the name Innovaderm and will continue to conduct dermatology studies.

Turning Science Into Efficient Aesthetics Trials

Aesthetic medicine is a rapidly evolving field that significantly enhances patients’ quality of life through innovative treatments and procedures. With over 25 years of dedicated experience in both aesthetic and medical aesthetics, Indero has been at the forefront of this transformation. With deep medical expertise and extensive operational experience, we can help you design a study that meets scientific objectives with the well-being of subjects in mind. Whether it’s developing new dermal fillers, neurotoxins, or other aesthetic treatments, we are committed to advancing the field with precision and care.

Aesthetics Indications

Indero provides expertise across a range of aesthetic and medical dermatology indications, including:
  • Dermal fillers
  • Submental fat
  • Scarring
  • Forehead lines
  • Photo aging
  • Crow’s feet lines and glabellar lines
  • Cheek augmentation
  • Sunscreen
  • Sun allergy
  • Skin aging
  • Sensitization
  • Irritation
  • Medical devices
  • Oily skin

Our Tailored Expertise

Secrets to Success

  • Study Design: Developing meticulously designed aesthetic studies.
  • Investigator Sites: Establishing robust relationships with our affiliated sites in the aesthetic space.
  • Innovaderm CRU: Synergy, possibility, and competitive pricing advantages of conducting single-center studies at our CRU.
  • Study Conduct: Authorities in the field with a firm grasp of relevant aesthetic operational considerations.
  • Data Quality: Maintaining high enrollment rates while prioritizing subject safety and high data quality.
 

At Indero, we understand the nuances related to patient and healthy volunteer recruitment, optimizing data integrity through informed selection of assessment tools and sites, and streamlined strategies to manage cost-effective studies leveraging our aesthetic dermatology know-how.

Aesthetics CRO Services

Indero offers a full-service in-house model for aesthetics clinical trials. From design to execution, we provide customized solutions to meet your study’s unique needs.

Why Indero?

Indero is a global clinical leader in aesthetics and medical dermatology with over a quarter century’s experience serving a broad range of indications, patient populations, administration routes, and drug classes. From protocol design to data delivery, we offer a full-service approach that equips biotech and pharmaceutical sponsors with the scientific rigor and targeted expertise to help bring novel therapies to people with skin diseases. Our operations span across the world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Our dermatology connections include over 3,100+ investigators, making us a trusted partner for efficient, effective aesthetics trials at a global scale.

“Working with Indero for our alopecia areata trial has been a smooth and exceptional experience, marked by their extensive expertise, proactive approach, and seamless collaboration.”

Duong Nguyen

Head of Clinical Operations

Our Secrets to Success

Study Design

Developing meticulously designed aesthetic studies.

Investigator Sites

Establishing robust relationships with our affiliated sites in the aesthetic space.

Innovaderm CRU

Synergy, possibility, and competitive pricing: the advantages of conducting single center studies at the CRU.

Study Conduct

We are the authorities in this field and have a firm grasp of the relevant aesthetic operational considerations.

Data Quality

Maintaining high enrollment rates, while prioritizing subject safety and high data quality.

One of the Largest Dermatology CRUs in North America

Innovaderm is a dermatology-focused Clinical Research Unit (CRU) well suited for single or multicenter dermatology studies. With a database of +90,000 patients, Innovaderm CRU has a dedicated team of study coordinators, lab technicians, research nurses, data entry specialists, regulatory specialists, and recruitment professionals.

Our Vast Dermatology Connections

Indero has cultivated relationships with 3,100+ dermatology investigators around the world, actively contributing to the advancement of novel therapies for people with skin conditions. Developed over years of working together, we have strong relationships with these sites, allowing us to select the right sites for your trial. Our sites are ready to meet your enrollment requirements, ensuring your timelines and quality metrics are met.

Innovaderm CRU Among the Top 3 Enrollers in a Cheek Augmentation & Correction of Midface Contour Deficiencies Study

An aesthetic study involving an injectable implant with more than 200 subjects enrolled.

Challenges

  • Implementing 3D imaging during each subject visit and encountering delays in the delivery of medical equipment to our site have necessitated a faster pace in recruiting patients.
  • Recruitment commenced during the summer period, which was not ideal as many patients were away on holiday.

Strategy

  • In contrast to other sites, we’ve achieved excellent subject retention by enrolling individuals familiar with Innovaderm or who had participated in comparable trials previously.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.